This Week's Global Pharma News] Roche and Pfizer Receive US FDA Approvals, argenx Discontinues Phase 3 Trial, New ...
A comprehensive look at the safety data from the MARIPOSA-2 trial, including rates of adverse events, toxicities, and treatment modifications across the three regimens. Specific details are provided ...
17 year old girl diagnosed with multiple sclerosis. Her symptoms started 1 day after her 2nd Pfizer shot. @OpenVAERS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results